scholarly journals Serum folate and whole blood global DNA methylation response to chronic folic acid supplementation in normal weight and obese women of child‐bearing age (817.2)

2014 ◽  
Vol 28 (S1) ◽  
Author(s):  
Gail Kauwell ◽  
Marie Caudill ◽  
Dorothy Hausman ◽  
Hea Jin Park ◽  
Deanna Shade ◽  
...  
PLoS ONE ◽  
2011 ◽  
Vol 6 (9) ◽  
pp. e24976 ◽  
Author(s):  
Audrey Y. Jung ◽  
Yvo Smulders ◽  
Petra Verhoef ◽  
Frans J. Kok ◽  
Henk Blom ◽  
...  

2017 ◽  
Vol 87 (5-6) ◽  
pp. 271-278
Author(s):  
Deanna C. Shade ◽  
Hea Jin Park ◽  
Dorothy B. Hausman ◽  
Natalie Hohos ◽  
Richard B. Meagher ◽  
...  

Abstract. Folate, a water-soluble vitamin, is a key source of one-carbon groups for DNA methylation, but studies of the DNA methylation response to supplemental folic acid yield inconsistent results. These studies are commonly conducted using whole blood, which contains a mixed population of white blood cells that have been shown to confound results. The objective of this study was to determine if CD16+ neutrophils may provide more specific data than whole blood for identifying DNA methylation response to chronic folic acid supplementation. The study was performed in normal weight (BMI 18.5 – 24.9 kg/m2) women (18 – 35 y; n = 12), with blood samples taken before and after 8 weeks of folic acid supplementation at 800 μg/day. DNA methylation patterns from whole blood and isolated CD16+ neutrophils were measured across >485,000 CpG sites throughout the genome using the Infinium HumanMethylation450 BeadChip. Over the course of the 8-week supplementation, 6746 and 7513 CpG sites changed (p < 0.05) in whole blood and CD16+ neutrophils, respectively. DNA methylation decreased in 68.4% (whole blood) and 71.8% (CD16+ neutrophils) of these sites. There were only 182 CpG sites that changed in both the whole blood and CD16+ neutrophils, 139 of which changed in the same direction. These results suggest that the genome-wide DNA methylation response to chronic folic acid supplementation is different between whole blood and CD16+ neutrophils and that a single white blood cell type may function as a more specific epigenetic reporter of folate status than whole blood.


2020 ◽  
Vol 90 (3-4) ◽  
pp. 353-364 ◽  
Author(s):  
Süleyman Köse ◽  
Saniye Sözlü ◽  
Hatice Bölükbaşi ◽  
Nüket Ünsal ◽  
Makbule Gezmen-Karadağ

Abstract. Objective: The aim of the present study is to perform a systemic review of the previous studies executed on the association between obesity and folate. Method: In the present research, the selected keywords were scanned on the PubMed, Web of Science, Cochrane and Lilac databases between May and June, 2017 through Gazi University’s network. In total, 4236 clinical, randomized controlled, cross-sectional and prospective studies were determined and 17 of these that specifically fit the aims of the present research were reviewed. This study involved an electronic literature search of databases on folic acid and obesity published in the English language between 2000 and 2016. Results: Of the 17 studies, 5 were based on folic acid supplementation and 12 were related with participants’ folate status. As a general consequence of both intake and serum/status measurements of folic acid supplementation: It was found that obesity-associated metabolic changes might affect individual folate use and obese individuals had lower serum folate levels, although there was no change in folate intake. Conclusion: Overweight and obese individuals have lower serum folate concentrations when compared with individuals with normal weight. It is explained by increased use of folic acid, urinary excretion, dilution of blood volume, different levels in different tissues and changes in the endocrine functions of folate. Individuals with higher Body Mass Indexes have less supplement use, unhealthier diets and donot consume sufficient vegetables and fruits, all of which can affect decrease in folate levels. Furthermore, adiposity may affect folate absorption by intestinal epithelium.


2017 ◽  
Vol 11 (6) ◽  
pp. 665-676 ◽  
Author(s):  
Hea Jin Park ◽  
Lynn B. Bailey ◽  
Deanna C. Shade ◽  
Dorothy B. Hausman ◽  
Natalie M. Hohos ◽  
...  

2016 ◽  
Vol 19 (14) ◽  
pp. 2572-2579 ◽  
Author(s):  
Minxue Shen ◽  
Shazia Hira Chaudhry ◽  
Amanda J MacFarlane ◽  
Laura Gaudet ◽  
Graeme N Smith ◽  
...  

AbstractObjectiveTo examine the association between BMI and folate concentrations in serum and red blood cells (RBC) in pregnant women.DesignA cross-sectional comparison of folate concentrations in serum and RBC sampled simultaneously from the same individual.SettingThe Ottawa Hospital and Kingston General Hospital, Ontario, Canada.SubjectsPregnant women recruited between 12 and 20 weeks of gestation.ResultsA total of 869 pregnant women recruited from April 2008 to April 2009 were included in the final analysis. Serum folate was inversely associated and RBC folate positively associated with BMI, after adjusting for folic acid supplementation, age, gestational age at blood sample collection, race, maternal education, annual income, smoking and MTHFR 677C→T genotype. In stratified analyses, this differential association was significant in women with the MTHFR CC variant. In women with the CT and TT variants, the differential associations were in the same direction but not significant. Folic acid supplementation during pregnancy did not alter the differential association of BMI with serum and RBC folate concentration. This indicates that the current RBC folate cut-off approach for assessing risk of neural tube defects in obese women may be limited.ConclusionsBMI is inversely associated with serum folate and positively associated with RBC folate in pregnant women, especially for those with the MTHFR CC variant.


2008 ◽  
Vol 22 (S1) ◽  
Author(s):  
Jason O Brant ◽  
Jiang‐Hui Zhu ◽  
Krista Crider ◽  
R J Berry ◽  
Ling Hao ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document